This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe

Poster Submission Deadline is April 7

  • 00
  • 00
  • 00
  • 00
Mark Your Calendar for BPI Europe 2023!
9-12 May 2023RAI in Amsterdam

Tarik Senussi
Snr Director of Process, Formulation Development & MSAT at Gyroscope Therapeutics


Tarik Senussi is the Director of process, formulation development & MSAT at Gyroscope Therapeutics Ltd a Novartis company. Tarik joined Gyroscope in February 2017, developing upstream and downstream processes for rAAV manufacture in suspension to support GT005 and other pipeline programmes. Prior to Joining Gyroscope Tarik was at GSK, establishing the upstream process development team to produce viral vectors and support the MMA for Strimvellis. Prior to that Tarik worked at Medimmune and Lonza Biologics. Tarik holds a BSc in Cell Biology and a PhD in Biochemical Engineering both from University College London.

Agenda Sessions

  • Panel Discussion: Designing The Facility of the Future